Literature DB >> 7667907

Antigenic differences between European and American isolates of porcine reproductive and respiratory syndrome virus (PRRSV) are encoded by the carboxyterminal portion of viral open reading frame 3.

J B Katz1, A L Shafer, K A Eernisse, J G Landgraf, E A Nelson.   

Abstract

Antigenic differences between European and American isolates of porcine reproductive and respiratory syndrome virus (PRRSV) were revealed by serologic analysis of a recombinant protein derived from PRRSV open reading frame 3 (ORF 3). The hydrophilic carboxyterminal 199 amino acids encoded by the ORF 3 of a European (Lelystad) isolate of PRRSV were expressed as a recombinant fusion protein (BP03-P) in a baculovirus gene expression system. Sera from gnotobiotic swine exposed to prototypic reference European and American isolates of PRRSV and sera from conventionally reared European and American swine convalescing from naturally acquired PRRSV infections were used to characterize the BP03-P protein. Sera from gnotobiotic and conventionally reared swine exposed to European isolates of PRRSV were significantly more reactive (P < 0.01) with BP03-P than were the corresponding American PRRSV antisera using the indirect immunoperoxidase monolayer assay (IPMA). Prototypic European, but not American, PRRSV antisera also recognized BP03-P using western immunoblotting and radioimmunoprecipitation assay (RIPA) procedures. However, gnotobiotically derived antiserum to an atypical American-origin PRRSV was reactive with BP03-P by both IPMA and western immunoblot. Despite a predicted potential for N-linked glycosylation, studies with tunicamycin and peptide-N-glycosidase F (PNGase F) indicated that BP03-P was not N-glycosylated in either insect cell cultures or Trichoplusia ni larvae infected with the recombinant baculovirus. Sera from rabbits inoculated with BP03-P failed to neutralize both the European (Lelystad) and American (ATCC VR-2332) reference isolates of PRRSV and did not react by IPMA with PRRSV-infected cell cultures. Taken together, the data suggest that the carboxyterminal portion of PRRSV ORF 3 encodes a non-neutralizing viral peptide that is partially responsible for the serologic differences noted between European and most American isolates of PRRSV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667907      PMCID: PMC7117291          DOI: 10.1016/0378-1135(94)00113-b

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  22 in total

1.  Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332).

Authors:  D A Benfield; E Nelson; J E Collins; L Harris; S M Goyal; D Robison; W T Christianson; R B Morrison; D Gorcyca; D Chladek
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

2.  Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled.

Authors:  C Terpstra; G Wensvoort; J M Pol
Journal:  Vet Q       Date:  1991-07       Impact factor: 3.320

3.  'Blue ear' disease of pigs.

Authors:  D J Paton; I H Brown; S Edwards; G Wensvoort
Journal:  Vet Rec       Date:  1991-06-29       Impact factor: 2.695

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Serologic survey for Lelystad and VR-2332 strains of porcine respiratory and reproductive syndrome (PRRS) virus in US swine herds.

Authors:  E M Bautista; S M Goyal; J E Collins
Journal:  J Vet Diagn Invest       Date:  1993-10       Impact factor: 1.279

6.  Antigenic comparison of Lelystad virus and swine infertility and respiratory syndrome (SIRS) virus.

Authors:  G Wensvoort; E P de Kluyver; E A Luijtze; A den Besten; L Harris; J E Collins; W T Christianson; D Chladek
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

7.  Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line.

Authors:  H S Kim; J Kwang; I J Yoon; H S Joo; M L Frey
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily.

Authors:  J A den Boon; E J Snijder; E D Chirnside; A A de Vries; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV).

Authors:  E K Godeny; L Chen; S N Kumar; S L Methven; E V Koonin; M A Brinton
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

10.  Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV.

Authors:  J J Meulenberg; M M Hulst; E J de Meijer; P L Moonen; A den Besten; E P de Kluyver; G Wensvoort; R J Moormann
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

View more
  17 in total

1.  Analysis of immunogenicity of minor envelope protein GP3 of porcine reproductive and respiratory syndrome virus in mice.

Authors:  Wenming Jiang; Ping Jiang; Yufeng Li; Xianwei Wang; Yijun Du
Journal:  Virus Genes       Date:  2007-08-01       Impact factor: 2.332

2.  A new porcine reproductive and respiratory syndrome virus strain with highly conserved molecular characteristics in its parental and attenuated strains.

Authors:  Xing Liu; Yufeng Li; Qi Lu; Juan Bai; Xiaoye Wang; Ping Jiang
Journal:  Virus Genes       Date:  2014-05-25       Impact factor: 2.332

3.  Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes.

Authors:  M B Oleksiewicz; A Bøtner; P Toft; P Normann; T Storgaard
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Typing of porcine reproductive and respiratory syndrome viruses by a multiplex PCR assay.

Authors:  S A Gilbert; R Larochelle; R Magar; H J Cho; D Deregt
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions.

Authors:  J F Hedges; U B Balasuriya; P J Timoney; W H McCollum; N J MacLachlan
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  North American porcine reproductive and respiratory syndrome viruses inhibit type I interferon production by plasmacytoid dendritic cells.

Authors:  Gabriela Calzada-Nova; William M Schnitzlein; Robert J Husmann; Federico A Zuckermann
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

7.  Identification of a novel structural protein of arteriviruses.

Authors:  E J Snijder; H van Tol; K W Pedersen; M J Raamsman; A A de Vries
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Molecular characterization of ORFs 2 to 7 of Korean porcine reproductive and respiratory syndrome virus (CA) and its protein expression by recombinant baculoviruses.

Authors:  Hyun Na Koo; Jeong Mi Oh; Jae Kyung Lee; Jae Young Choi; Kwang Sik Lee; Jong Yul Roh; Yeon Ho Je; Byung Rae Jin; Sung Sik Yoo; Jae Su Kim; Young In Kim; In Joong Yoon; Soo Dong Woo
Journal:  J Microbiol       Date:  2008-12-24       Impact factor: 3.422

9.  Characterization of emerging European-like porcine reproductive and respiratory syndrome virus isolates in the United States.

Authors:  Susan L Ropp; Carrie E Mahlum Wees; Ying Fang; Eric A Nelson; Kurt D Rossow; Melissa Bien; Bill Arndt; Sarah Preszler; Pamela Steen; Jane Christopher-Hennings; James E Collins; David A Benfield; Kay S Faaberg
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  A subset of porcine reproductive and respiratory syndrome virus GP3 glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form.

Authors:  H Mardassi; P Gonin; C A Gagnon; B Massie; S Dea
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.